Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisal

被引:126
|
作者
Shah, Nilesh [2 ]
Pang, Brendan [1 ]
Yeoh, Khay-Guan [2 ,3 ]
Thorn, Shannon [4 ]
Chen, Chien Shiny [2 ,3 ]
Lilly, Michael B. [5 ]
Salto-Tellez, Manuel [1 ,2 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Pathol, Singapore 117595, Singapore
[2] Natl Univ Singapore, Oncol Res Inst, Singapore 117595, Singapore
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Med, Singapore 117595, Singapore
[4] Univ Arizona, Arizona Hlth Sci Ctr, Dept Med, Infect Dis Sect, Tucson, AZ USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA
关键词
PIM1; Kinase; Lymphomas; Carcinomas; Target inhibitors;
D O I
10.1016/j.ejca.2008.06.044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In vitro experiments have shown the PIM1 kinase to have diverse biological roles in cell survival, proliferation and differentiation. In humans, PIM1 is often expressed in both normal and transformed cells. The PIM1 kinase is a true oncogene implicated in early transformation and tumour progression in haematopoietic malignancies and prostate carcinomas. it is associated with aggressive subgroups of lymphoma, is a marker of poor prognosis in prostate carcinomas and has been suggested to have a role in hormone insensitivity of prostate malignancies. PIM1 has a possible role in other carcinomas with 6p21 genomic alterations. On one hand, PIM1 (due to its role in malignancy) appears to be a promising target for drug development programmes but, on the other hand, the complexity of its molecular structure has posed challenges in the development of PIM1 inhibitors. In this review we discuss PIM1 expression in human tissues (including some new data from our laboratory), its role in human malignancies, as well as the possibilities and challenges in the development of target therapy for PIM1. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2144 / 2151
页数:8
相关论文
共 50 条
  • [1] Clinical and therapeutic relevance of PIM1 kinase in gastric cancer
    Yan, Benedict
    Yau, Ee Xuan
    Samanta, Sanjay
    Ong, Chee Wee
    Yong, Kol Jia
    Ng, Lai Kuan
    Bhattacharya, Bhaskar
    Lim, Kiat Hon
    Soong, Richie
    Yeoh, Khay Guan
    Deng, Niantao
    Tan, Patrick
    Lam, Yulin
    Salto-Tellez, Manuel
    GASTRIC CANCER, 2012, 15 (02) : 188 - 197
  • [2] Clinical and therapeutic relevance of PIM1 kinase in gastric cancer
    Benedict Yan
    Ee Xuan Yau
    Sanjay Samanta
    Chee Wee Ong
    Kol Jia Yong
    Lai Kuan Ng
    Bhaskar Bhattacharya
    Kiat Hon Lim
    Richie Soong
    Khay Guan Yeoh
    Niantao Deng
    Patrick Tan
    Yulin Lam
    Manuel Salto-Tellez
    Gastric Cancer, 2012, 15 : 188 - 197
  • [3] PIM1 kinase as a target for cancer therapy
    Merkel, Anna Lena
    Meggers, Eric
    Ocker, Matthias
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (04) : 425 - 436
  • [4] A potential therapeutic target for FLT3-ITD AML: PIM1 kinase
    Fathi, Amir T.
    Arowojolu, Omotayo
    Swinnen, Ian
    Sato, Takashi
    Rajkhowa, Trivikram
    Small, Donald
    Marmsater, Fredrik
    Robinson, John E.
    Gross, Stefan David
    Martinson, Matthew
    Allen, Shelley
    Kallan, Nicholas C.
    Levis, Mark
    LEUKEMIA RESEARCH, 2012, 36 (02) : 224 - 231
  • [5] PIM1 is a potential therapeutic target for serous carcinoma of the endometrium
    Takeuchi, Hodaka
    Miyamoto, Tsutomu
    Asaka, Ryoichi
    Ono, Motoki
    Ida, Koichi
    Tanaka, Yasuhiro
    Shinagawa, Manaka
    Shiozawa, Tanri
    CANCER SCIENCE, 2021, 112 : 827 - 827
  • [6] PIM1 Kinase as a Target in Prostate Cancer: Roles in Tumorigenesis, Castration Resistance, and Docetaxel Resistance
    Holder, Sheldon L.
    Abdulkadir, Sarki A.
    CURRENT CANCER DRUG TARGETS, 2014, 14 (02) : 105 - 114
  • [7] Structural Investigation of Pim1 Kinase
    Parker, Lorien Jane
    Handa, Noriko
    Shirouzu, Mikako
    Yokoyama, Shigeyuki
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C304 - C304
  • [8] Synergy of PIM1 kinase with c-MYC in prostate cancer
    Wang, Jie
    Kim, Jongchan
    Roh, Meejeon
    Franco, Omar E.
    Martinez, Erin
    Hayward, Simon W.
    Wills, Marcia L.
    Abdulkadir, Sarki A.
    CANCER RESEARCH, 2010, 70
  • [9] Synthesis of a carbon-11-labeled PIM1 inhibitor as a new potential PET agent for imaging of PIM1 in cancer
    Gao, Mingzhang
    Wang, Min
    Zheng, Qi-Huang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [10] Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis
    Li, He
    Xie, Lihui
    Zhu, Lei
    Li, Zhaohuai
    Wang, Rong
    Liu, Xiuxing
    Huang, Zhaohao
    Chen, Binyao
    Gao, Yuehan
    Wei, Lai
    He, Chang
    Ju, Rong
    Liu, Yizhi
    Liu, Xialin
    Zheng, Yingfeng
    Su, Wenru
    NATURE COMMUNICATIONS, 2022, 13 (01)